Stephen Wright
Nessuna posizione attualmente
Profilo
Stephen Wright served as the Executive Director & Chief Medical Officer at GW Pharmaceuticals Ltd.
from 2004 to 2017.
Prior to that, he held positions as Director-Immunology, Inflammation & Dermatology at Scotia Pharmaceuticals Ltd.
and Senior VP-Clinical Research & Development at Ipsen Ltd.
Wright received his graduate and doctorate degrees from the University of Cambridge and his undergraduate degree from Royal Holloway University of London.
Precedenti posizioni note di Stephen Wright
Società | Posizione | Fine |
---|---|---|
GW PHARMACEUTICALS PLC | Direttore Tecnico/Scientifico/R&S | 01/05/2017 |
Scotia Pharmaceuticals Ltd.
Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Scotia Pharmaceuticals Ltd. engages in a pharmaceutical company. The company was founded on November 2, 1978 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - |
Ipsen Ltd.
Ipsen Ltd. Pharmaceuticals: MajorHealth Technology Ipsen Ltd. develops and markets medicinal products. The firm provides Decapepty, Disport, Hexvix, Increlex and Somatuline. The company is headquartered in Slough, the United Kingdom. | Corporate Officer/Principal | - |
Formazione di Stephen Wright
University of Cambridge | Doctorate Degree |
Royal Holloway University of London | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 3 |
---|---|
GW Pharmaceuticals Ltd.
GW Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology GW Pharmaceuticals Ltd. operates as an intermediate holding company and management company for investments in its subsidiaries. The company was founded by Geoffrey William Guy and Brian Whittle in 1998 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Ipsen Ltd.
Ipsen Ltd. Pharmaceuticals: MajorHealth Technology Ipsen Ltd. develops and markets medicinal products. The firm provides Decapepty, Disport, Hexvix, Increlex and Somatuline. The company is headquartered in Slough, the United Kingdom. | Health Technology |
Scotia Pharmaceuticals Ltd.
Scotia Pharmaceuticals Ltd. Medical DistributorsDistribution Services Scotia Pharmaceuticals Ltd. engages in a pharmaceutical company. The company was founded on November 2, 1978 and is headquartered in London, the United Kingdom. | Distribution Services |
- Borsa valori
- Insiders
- Stephen Wright